Speakers 2012

  • ABD EL-FATTAH Sherif

    Egypt

      Presentation

    • How to optimize treatment of G1 patient ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 2

    View more
    • Presentation

    • How to optimize treatment of G4 patients (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 4

    • Controversies Part 1 (chairman) - Tuesday, January 31st 2012 - 8:45-10:15

    View more
  • AGHEMO Alessio

    Italy

      Presentation

    • How to optimize treatment of G2 and G3 patients - Monday, January 30th 2012 - Interactive luncheons - Room 3

    View more
  • ALBERTI Alfredo

    Italy

      Presentation

    • What’s new in non G1 ? (chairman) - Monday, January 30th 2012 - 14:30 – 15:30

    • How to manage non responders and relapsers ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 5

    View more
  • ANTAKI Nabil

    Syria

      Presentation

    • How to optimize treatment of G4 patients - Monday, January 30th 2012 - Interactive luncheons - Room 4

    View more
  • ASSELAH Tarik

    France

      Presentation

    • Future therapies (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 7

    • State of the Art Lecture (chairman) - Tuesday, January 31st 2012 - 11:45

    • State of the Art Lecture (chairman) - Tuesday, January 31st 2012 - 14:30 – 15:00

    • Advantages of new generation DAAs - Tuesday, January 31st 2012 - 15:00

    View more
  • BACON Bruce

    USA

      Presentation

    • Boceprevir - Monday, January 30th 2012 - 11:10

    View more
  • BARTENSCHLAGER Ralf

    Germany

      Presentation

    • New targets for antivirals against HCV - Tuesday, January 31st 2012 -

    • Future therapies - Tuesday, January 31st 2012 - Interactive Luncheons - Room 7

    View more
  • BEDOSSA Pierre

    France

      Presentation

    • Non invasive markers of fibrosis (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 8

    View more
  • BELHADJ BRIK Najet

    Tunisia

      Presentation

    • French speaking luncheon : Comment optimiser le traitement des patients naifs - Monday, January 30th 2012 - Interactive luncheons - Room 1

    View more
  • BENAZZOUZ Mustapha

    Morocco

      Presentation

    • French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs - Tuesday, January 31st 2012 - Interactive Luncheons - Room 1

    View more
  • BERENGUER Marina

    Spain

      Presentation

    • How to optimize treatment of G1 patient ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 2

    View more
    • Presentation

    • Cirrhotics - Monday, January 30th 2012 - 16:00

    View more
  • BRONOWICKI Jean-Pierre

    France

      Presentation

    • How to manage G1 relapsers and non responders ? - Monday, January 30th 2012 - Interactive luncheons - Room 5

    View more
  • BUTI FERRET Maria

    Spain

      Presentation

    • How to manage non responders and relapsers ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 5

    View more
  • CALES Paul

    France

      Presentation

    • Non invasive markers of fibrosis - Monday, January 30th 2012 - Interactive luncheons - Room 8

    View more
  • CARDOSO Ana Carolina

    Brazil

      Presentation

    • Non invasive markers of fibrosis - Monday, January 30th 2012 - Interactive luncheons - Room 8

    View more
  • CASTERA Laurent

    France

      Presentation

    • Treatment of patients with cirrhosis - Tuesday, January 31st 2012 - Interactive Luncheons - Room 8

    View more
  • COLOMBO Massimo

    Italy

      Presentation

    • Triple therapy today. Phase III results in G1 naïve patients (chairman) - Monday, January 30th 2012 - 8:45 – 10:15

    • How to optimize treatment of non G1 patient ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 3

    View more
  • COUZIGOU Patrice

    France

      Presentation

    • French speaking luncheon : Comment optimiser le traitement des patients naifs (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 1

    View more
  • CRAXI Antonio

    Italy

      Presentation

    • The EASL HCV Clinical Practice Guidelines - Monday, January 30th 2012 -

    • How to optimize treatment of G1 patient ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 2

    View more
  • DE LEDINGHEN Victor

    France

      Presentation

    • Non invasive markers of fibrosis - Monday, January 30th 2012 - Interactive luncheons - Room 8

    View more
  • DUSHEIKO Geoffrey

    UK

      Presentation

    • Triple therapy today. Phase III results in G1 relapsers and non responders (chairman) - Monday, January 30th 2012 - 10:50 – 12:00

    View more
  • ESMAT Gamal

    Egypt

      Presentation

    • Genotype 4 - Monday, January 30th 2012 - 15:00

    View more
  • FERENCI Peter

    Austria

      Presentation

    • Are interferons really necessary ? - Tuesday, January 31st 2012 - 15:40

    View more
  • FLISIAK Robert

    Poland

      Presentation

    • Future therapies - Tuesday, January 31st 2012 - Interactive Luncheons - Room 7

    View more
  • FOSTER Graham

    UK

      Presentation

    • How to optimize treatment of G2 and G3 patients (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 3

    • How to optimize treatment of G2 and G3 patients - Monday, January 30th 2012 - Interactive luncheons - Room 3

    • Genotype 3 - Monday, January 30th 2012 - 14:45

    • Lead in or no lead in ? - Tuesday, January 31st 2012 - 9:15

    View more
    • Presentation

    • How to optimize treatment of G1 patients (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 2

    • How to improve access to therapy - Tuesday, January 31st 2012 -

    View more
  • HALFON Philippe

    France

      Presentation

    • Resistance is important : Yes or No ? - Tuesday, January 31st 2012 - 11:15

    View more
  • HEZODE Christophe

    France

      Presentation

    • Safety management in clinical practicee - Monday, January 30th 2012 - 9:25

    View more
  • HOOFNAGLE Jay

    USA

      Presentation

    • The history of HCV therapy - Monday, January 30th 2012 -

    View more
  • HORBAN Andrzej

    Poland

      Presentation

    • How to optimize treatment of G1 patient ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 2

    View more
    • Presentation

    • Telaprevir - Monday, January 30th 2012 - 8:45

    View more
    • Presentation

    • How to manage sides effects of triple therapy ? (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 6

    • Do IL28B or not do IL28B ? - Tuesday, January 31st 2012 - 10:45

    View more
  • JIA Ji Dong

    China

      Presentation

    • The future (chairman) - Tuesday, January 31st 2012 - 15:00 - 16:15

    View more
  • KAO Jia-Horng

    Taiwan

      Presentation

    • What’s new in non G1 ? (chairman) - Monday, January 30th 2012 - 14:30 – 15:30

    View more
  • KWO Paul

    USA

      Presentation

    • Clinical relevance of predictors - Monday, January 30th 2012 - 9:40

    View more
  • LADA Olivier

    France

      Presentation

    • How to avoid a resistance issue ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 4

    View more
  • LAU George

    Hong Kong

      Presentation

    • How to optimize treatment of G1 patients - Monday, January 30th 2012 - Interactive luncheons - Room 2

    View more
  • LEE Sam

    Canada

      Presentation

    • How to manage sides effects of triple therapy ? - Monday, January 30th 2012 - Interactive luncheons - Room 6

    • Special Populations (chairman) - Monday, January 30th 2012 - 16:00 – 17:00

    View more
  • LEROY Vincent

    France

      Presentation

    • How to manage sides effects of triple therapy ? - Monday, January 30th 2012 - Interactive luncheons - Room 6

    View more
  • LEVRERO Massimo

    Italy

      Presentation

    • Future therapies - Monday, January 30th 2012 - Interactive luncheons - Room 7

    View more
    • Presentation

    • The future (chairman) - Tuesday, January 31st 2012 - 15:00 - 16:15

    View more
  • MANGIA Alessandra

    Italy

      Presentation

    • Genotype 2 - Monday, January 30th 2012 - 14:30

    • How to optimize treatment of non G1 patient ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 3

    View more
  • MANNS Michael

    Germany

      Presentation

    • Triple therapy today. Phase III results in G1 naïve patients (chairman) - Monday, January 30th 2012 - 8:45 – 10:15

    • Boceprevir - Monday, January 30th 2012 - 9:05

    • How to manage G1 relapsers and non responders ? (chairman) - Monday, January 30th 2012 - Interactive luncheons - Room 5

    View more
  • MARCELLIN Patrick

    France

      Presentation

    • Introduction : Hepatitis C : A big step towards eradication - Monday, January 30th 2012 -

    • State of the Art Lecture (chairman) - Monday, January 30th 2012 - 12:00 – 12:30

    • State of the Art Lecture (chairman) - Monday, January 30th 2012 - 17:00

    • Introduction - Monday, January 30th 2012 -

    • Introduction - Tuesday, January 31st 2012 -

    • Conclusion and perspectives - Tuesday, January 31st 2012 - 16:15 -16:30

    View more
  • MATHURIN Philippe

    France

      Presentation

    • How to optimize treatment of G4 patients - Monday, January 30th 2012 - Interactive luncheons - Room 4

    View more
  • MOUCARI Rami

    United Arab Emirates

      Presentation

    • How to optimize treatment of non G1 patient ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 3

    View more
  • NEGRO Francesco

    Switzerland

      Presentation

    • Future therapies - Monday, January 30th 2012 - Interactive luncheons - Room 7

    View more
    • Presentation

    • Future therapies (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 7

    • Is Ribavirin still useful ? - Tuesday, January 31st 2012 - 15:20

    View more
  • OMATA Masao

    Japan

      Presentation

    • Controversies Part 2 (chairman) - Tuesday, January 31st 2012 - 10:45-11:45

    View more
  • OULD GOUGAM Rachid

    Algeria

      Presentation

    • French speaking luncheon : Comment optimiser le traitement des patients naifs - Monday, January 30th 2012 - Interactive luncheons - Room 1

    View more
  • OUZAN Denis

    France

      Presentation

    • French speaking luncheon : Comment optimiser le traitement des patients naifs - Monday, January 30th 2012 - Interactive luncheons - Room 1

    View more
  • PAPATHEODORIDIS Georgios

    Greece

      Presentation

    • How to manage G1 relapsers and non responders ? - Monday, January 30th 2012 - Interactive luncheons - Room 5

    View more
  • PIRATVISUTH Teerha

    Thailand

      Presentation

    • Special Populations (chairman) - Monday, January 30th 2012 - 16:00 – 17:00

    View more
  • POL Stanislas

    France

      Presentation

    • Do IL28B or not do IL28B ? - Tuesday, January 31st 2012 - 10:45

    View more
  • RATZIU Vlad

    France

      Presentation

    • How to manage sides effects of triple therapy ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 6

    View more
  • REDDY Raj

    USA

      Presentation

    • Response unguided or guided ? - Tuesday, January 31st 2012 - 9:45

    View more
  • SAMUEL Didier

    France

      Presentation

    • Pre and post liver transplantation - Monday, January 30th 2012 - 16:15

    View more
  • SARRAZIN Christoph

    Germany

      Presentation

    • Resistance is important : Yes or No ? - Tuesday, January 31st 2012 - 11:15

    View more
  • SCHIFF Eugene

    USA

      Presentation

    • Triple therapy today. Phase III results in G1 relapsers and non responders (chairman) - Monday, January 30th 2012 - 10:50 – 12:00

    • How to manage sides effects of triple therapy ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 6

    View more
  • SCHINAZI Raymond

    USA - Georgia

      Presentation

    • Introduction : Is the game over ? - Tuesday, January 31st 2012 -

    View more
  • SERFATY Lawrence

    France

      Presentation

    • Lead in or no lead in ? - Tuesday, January 31st 2012 - 9:15

    • How to manage non responders and relapsers ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 5

    View more
  • SHIFFMAN Mitchell

    USA

      Presentation

    • Telaprevir or Boceprevir ? - Tuesday, January 31st 2012 - 8:45

    • How to avoid a resistance issue ? (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 4

    View more
  • SULKOWSKI Mark

    USA

      Presentation

    • Future therapies - Monday, January 30th 2012 - Interactive luncheons - Room 7

    • HCV-HIV coinfection - Monday, January 30th 2012 - 16:30

    View more
  • THURSZ Mark

    UK

      Presentation

    • Controversies Part 2 (chairman) - Tuesday, January 31st 2012 - 10:45-11:45

    • Treatment of patients with cirrhosis - Tuesday, January 31st 2012 - Interactive Luncheons - Room 8

    View more
  • TRAN Albert

    France

      Presentation

    • French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs - Tuesday, January 31st 2012 - Interactive Luncheons - Room 1

    View more
  • TREPO Christian

    France

      Presentation

    • French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 1

    View more
  • VALLA Dominique

    France

      Presentation

    • Treatment of patients with cirrhosis (chairman) - Tuesday, January 31st 2012 - Interactive Luncheons - Room 8

    View more
  • VOICULESCU Mihai

    Romania

      Presentation

    • French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs - Tuesday, January 31st 2012 - Interactive Luncheons - Room 1

    View more
  • WAKED Imam

    Egypt

      Presentation

    • How to optimize treatment of G4 patients - Monday, January 30th 2012 - Interactive luncheons - Room 4

    View more
  • WEILAND Ola

    Sweden

      Presentation

    • How to manage sides effects of triple therapy ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 6

    View more
  • YURDAYDIN Cihan

    Turkey

      Presentation

    • How to optimize treatment of G1 patients - Monday, January 30th 2012 - Interactive luncheons - Room 2

    View more
  • ZARSKI Jean-Pierre

    France

      Presentation

    • Controversies Part 1 (chairman) - Tuesday, January 31st 2012 - 8:45-10:15

    View more
  • ZEUZEM Stefan

    Germany

      Presentation

    • Telaprevir - Monday, January 30th 2012 - 10:50

    View more
  • ZOULIM Fabien

    France

      Presentation

    • Response unguided or guided ? - Tuesday, January 31st 2012 - 9:45

    • How to avoid a resistance issue ? - Tuesday, January 31st 2012 - Interactive Luncheons - Room 4

    View more